关注
Wilasinee Dunkoksung
Wilasinee Dunkoksung
在 chula.ac.th 的电子邮件经过验证
标题
引用次数
引用次数
年份
Rhinacanthin-C mediated herb-drug interactions with drug transporters and phase I drug-metabolizing enzymes
W Dunkoksung, N Vardhanabhuti, P Siripong, S Jianmongkol
Drug Metabolism and Disposition 47 (10), 1040-1049, 2019
112019
Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier
W Dunkoksung, N Vardhanabhuti, S Jianmongkol
Journal of Pharmacy and Pharmacology 71 (2), 213-219, 2019
72019
Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive …
U Udomnilobol, W Dunkoksung, W Sakares, S Jianmongkol, ...
Frontiers in Pharmacology 15, 1356273, 2024
12024
Binding characteristics of pyrrole-scaffold hepatitis B virus capsid inhibitors and identification of novel potent compounds
T Ruengsatra, A Meeprasert, E Rattanangkool, S Deesiri, J Srisa, ...
RSC advances 13 (41), 29004-29022, 2023
12023
INTERACTION BETWEEN P-GLYCOPROTEIN AND THAI HERBS WITH ANTI DIABETIC POTENTIAL
W Dunkoksung, N Vardhanabhuti, S Amnuoypol, S Jianmongkol
The Thai Journal of Pharmaceutical Sciences 38, 99-102, 2013
12013
Design, synthesis, and optimization of novel PD-L1 inhibitors and the identification of a highly potent and orally bioavailable PD-L1 inhibitor
T Ruengsatra, J Soponpong, N Nalinratana, N Jirapongwattana, ...
European Journal of Medicinal Chemistry 277, 116730, 2024
2024
4-phenyl-indole derivatives and related uses
J Soponpong, T Ruengsatra, N Nalinratana, U Udomnilobol, S Ampawa, ...
US Patent App. 18/259,408, 2024
2024
Preclinical Characterization of a Novel Potent Core Protein Assembly Modulator for the Treatment of Chronic Hepatitis B Viral Infection
W Dunkoksung, U Udomnilobol, T Ruengsatra, N Chauypen, ...
European Journal of Pharmaceutical Sciences, 106834, 2024
2024
Pyrrolidine-3-carboxamide derivatives and related uses
T Ruengsatra, E Rattanangkool, P Chaiyakunvat, S Deesiri, ...
US Patent App. 18/250,012, 2023
2023
1371 Novel orally active and high tissue penetrant small molecules targeting surface and intracellular PD-L1 signals for cancer immunotherapy
N Nalinratana, N Jirapongwattana, U Udomnilobol, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
Permeability of phyllanthin across caco-2 cells
W Dunkoksung
Chulalongkorn University, 2013
2013
系统目前无法执行此操作,请稍后再试。
文章 1–11